Search Results

There are 16524 results for: content related to: A case of CD 8+ small/medium-sized pleomorphic T -cell lymphoma: clinical and histopathological differential diagnosis

  1. Indolent CD8-positive lymphoid proliferation of acral sites: identifying the sheep in wolf's clothing

    British Journal of Dermatology

    Volume 172, Issue 6, June 2015, Pages: 1480–1481, J.R. Goodlad

    Version of Record online : 2 JUN 2015, DOI: 10.1111/bjd.13765

  2. Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia

    Intervention Review

    The Cochrane Library

    Liat Vidal, Anat Gafter-Gvili, Ronit Gurion, Pia Raanani, Martin Dreyling and Ofer Shpilberg

    Published Online : 12 SEP 2012, DOI: 10.1002/14651858.CD009045.pub2

  3. Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient

    Journal of Cutaneous Pathology

    Volume 43, Issue 2, February 2016, Pages: 125–136, Justine Kluk, Anneke Kai, Dimitra Koch, Saleem M. Taibjee, Simon O'Connor, Mojca Persic, Stephen Morris, Sean Whittaker, Lorenzo Cerroni, Werner Kempf, Tony Petrella and Alistair Robson

    Version of Record online : 13 NOV 2015, DOI: 10.1111/cup.12633

  4. Rituximab as maintenance therapy for patients with follicular lymphoma

    Intervention Review

    The Cochrane Library

    Liat Vidal, Anat Gafter-Gvili, Leonard Leibovici and Ofer Shpilberg

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD006552.pub2

  5. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas

    British Journal of Dermatology

    Volume 172, Issue 6, June 2015, Pages: 1573–1580, M. Wobser, S. Roth, T. Reinartz, A. Rosenwald, M. Goebeler and E. Geissinger

    Version of Record online : 15 APR 2015, DOI: 10.1111/bjd.13628

  6. Extrafacial indolent CD8-positive cutaneous lymphoid proliferation with unusual symmetrical presentation involving both feet

    Journal of Cutaneous Pathology

    Volume 40, Issue 11, November 2013, Pages: 955–961, Marion Wobser, Tony Petrella, Hermann Kneitz, Andreas Kerstan, Matthias Goebeler, Andreas Rosenwald and Eva Geissinger

    Version of Record online : 18 SEP 2013, DOI: 10.1111/cup.12213

  7. You have full text access to this Open Access content
    Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma

    Cancer Science

    Volume 100, Issue 10, October 2009, Pages: 1951–1956, Kensei Tobinai, Ken-ichi Ishizawa, Michinori Ogura, Kuniaki Itoh, Yasuo Morishima, Kiyoshi Ando, Masafumi Taniwaki, Takashi Watanabe, Joji Yamamoto, Toshiki Uchida, Masanobu Nakata, Takashi Terauchi, Shigeru Nawano, Masaki Matsusako, Masaki Hayashi and Tomomitsu Hotta

    Version of Record online : 17 JUN 2009, DOI: 10.1111/j.1349-7006.2009.01247.x

  8. You have free access to this content
    Follicular lymphoma: 2012 update on diagnosis and management

    American Journal of Hematology

    Volume 87, Issue 10, October 2012, Pages: 988–995, Arnold Freedman*

    Version of Record online : 24 SEP 2012, DOI: 10.1002/ajh.23313

  9. Lymphoid Leukaemias of Mature T, B and Natural Killer Cells

    Leukaemia Diagnosis, Fourth Edition

    Barbara J. Bain, Pages: 301–376, 2010

    Published Online : 30 JUN 2010, DOI: 10.1002/9781444318470.ch6

  10. You have free access to this content
    A review of the solitary cutaneous T-cell lymphomas

    Journal of Cutaneous Pathology

    Volume 41, Issue 9, September 2014, Pages: 703–714, Mina S. Ally and Alistair Robson

    Version of Record online : 26 APR 2014, DOI: 10.1111/cup.12353

  11. Changing nodule on the right helix

    International Journal of Dermatology

    Cuong V. Nguyen, Daniel D. Miller and Sara A. Hylwa

    Version of Record online : 23 JUN 2016, DOI: 10.1111/ijd.13354

  12. You have free access to this content
    Guidelines on the investigation and management of follicular lymphoma

    British Journal of Haematology

    Volume 156, Issue 4, February 2012, Pages: 446–467, Christopher McNamara, John Davies, Martin Dyer, Peter Hoskin, Tim Illidge, Matthew Lyttelton, Robert Marcus, Silvia Montoto, Alan Ramsay, Wai Lup Wong and Kint Ardeshna

    Version of Record online : 23 DEC 2011, DOI: 10.1111/j.1365-2141.2011.08969.x

  13. Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation

    Veterinary and Comparative Oncology

    Volume 13, Issue 4, December 2015, Pages: 348–362, L. Aresu, V. Martini, F. Rossi, M. Vignoli, M. Sampaolo, A. Aricò, P. Laganga, A. Pierini, P. Frayssinet, R. Mantovani and L. Marconato

    Version of Record online : 20 JUN 2013, DOI: 10.1111/vco.12048

  14. Rituximab (Rituxan®)

    Handbook of Therapeutic Antibodies

    Axel Böhnke, Michael Wenger, Pages: 1909–2022, 2014

    Published Online : 12 AUG 2014, DOI: 10.1002/9783527682423.ch70

  15. Rituximab (Rituxan)

    Handbook of Therapeutic Antibodies

    Stefan Dübel, Pages: 1033–1108, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch39

  16. Correspondence article regarding CD68 as a marker of CD8+ lymphoid proliferation suggested by Wobser et al.

    British Journal of Dermatology

    Volume 174, Issue 5, May 2016, Pages: 1158–1159, K. Lecamwasam, B. Mathew, D. Gilson, C. Burton and P. Laws

    Version of Record online : 14 MAR 2016, DOI: 10.1111/bjd.14420

  17. You have free access to this content
    Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease

    British Journal of Haematology

    Volume 133, Issue 1, April 2006, Pages: 3–18, Bärbel Seyfarth, Andreas Josting, Martin Dreyling and Norbert Schmitz

    Version of Record online : 31 JAN 2006, DOI: 10.1111/j.1365-2141.2006.05975.x

    Corrected by:

    Erratum

    Vol. 134, Issue 4, 449, Version of Record online: 5 JUL 2006

  18. You have free access to this content
    Aiming at a Curative Strategy for Follicular Lymphoma

    CA: A Cancer Journal for Clinicians

    Volume 58, Issue 5, September/October 2008, Pages: 305–317, Dr. Maurizio Bendandi

    Version of Record online : 31 DEC 2008, DOI: 10.3322/CA.2008.0011

  19. A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy

    British Journal of Haematology

    Andre Goy, Andres Forero, Nina Wagner-Johnston, W. Christopher Ehmann, Michaela Tsai, Kiyohiko Hatake, Revathi Ananthakrishnan, Angela Volkert, Erik Vandendries and Michinori Ogura

    Version of Record online : 22 APR 2016, DOI: 10.1111/bjh.14094

  20. You have free access to this content
    Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma

    Cancer

    Volume 113, Issue 10, 15 November 2008, Pages: 2734–2741, Michael Wang, Luis Fayad, Fernando Cabanillas, Fredrick Hagemeister, Peter McLaughlin, Maria A Rodriguez, Larry W. Kwak, Yuhong Zhou, Hagop Kantarjian and Jorge Romaguera

    Version of Record online : 30 OCT 2008, DOI: 10.1002/cncr.23880